Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIKOSYN vs TILDRAKIZUMAB-ASMN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIKOSYN vs TILDRAKIZUMAB-ASMN: Safety Overview

Metric TIKOSYN TILDRAKIZUMAB-ASMN
Total FAERS Reports 285 1,621
Deaths Reported 13 92
Death Rate 4.6% 5.7%
Hospitalizations 40 69
Average Patient Age 69.3 yrs 63.8 yrs
% Female Patients N/A 53.8%
Marketing Status N/A Prescription